Literature DB >> 17363616

5-AZA-2'-deoxycytidine in cancer immunotherapy: a mouse to man story.

Sandra Coral, Luca Sigalotti, Alessia Covre, Hugues J M Nicolay, Pier Giorgio Natali, Michele Maio.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17363616     DOI： 10.1158/0008-5472.CAN-06-2986

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  7 in total

1.  Maintenance therapy with low-dose azacitidine after allogeneic hematopoietic stem cell transplantation for recurrent acute myelogenous leukemia or myelodysplastic syndrome: a dose and schedule finding study.

Authors:  Marcos de Lima; Sergio Giralt; Peter F Thall; Leandro de Padua Silva; Roy B Jones; Krishna Komanduri; Thomas M Braun; Hoang Q Nguyen; Richard Champlin; Guillermo Garcia-Manero
Journal:  Cancer       Date:  2010-07-29       Impact factor: 6.860

2.  The biology of cancer testis antigens: putative function, regulation and therapeutic potential.

Authors:  Elisabetta Fratta; Sandra Coral; Alessia Covre; Giulia Parisi; Francesca Colizzi; Riccardo Danielli; Hugues Jean Marie Nicolay; Luca Sigalotti; Michele Maio
Journal:  Mol Oncol       Date:  2011-02-18       Impact factor: 6.603

3.  Real-time PCR analysis of genes encoding tumor antigens in esophageal tumors and a cancer vaccine.

Authors:  Brian T Weinert; Kausilia K Krishnadath; Francesca Milano; Ayako W Pedersen; Mogens H Claesson; Mai-Britt Zocca
Journal:  Cancer Immun       Date:  2009-10-09

Review 4.  HLA antigen changes in malignant cells: epigenetic mechanisms and biologic significance.

Authors:  M Campoli; S Ferrone
Journal:  Oncogene       Date:  2008-10-06       Impact factor: 9.867

5.  Treatment of resistant metastatic melanoma using sequential epigenetic therapy (decitabine and panobinostat) combined with chemotherapy (temozolomide).

Authors:  Chang Xia; Roberto Leon-Ferre; Douglas Laux; Jeremy Deutsch; Brian J Smith; Melanie Frees; Mohammed Milhem
Journal:  Cancer Chemother Pharmacol       Date:  2014-07-26       Impact factor: 3.333

Review 6.  Targeting Epigenetic Modifications in Uveal Melanoma.

Authors:  Pooneh Chokhachi Baradaran; Zuzana Kozovska; Alena Furdova; Bozena Smolkova
Journal:  Int J Mol Sci       Date:  2020-07-27       Impact factor: 5.923

7.  Epigenetic remodelling of gene expression profiles of neoplastic and normal tissues: immunotherapeutic implications.

Authors:  S Coral; A Covre; H J M G Nicolay; G Parisi; A Rizzo; F Colizzi; S Dalla Santa; E Fonsatti; E Fratta; L Sigalotti; M Maio
Journal:  Br J Cancer       Date:  2012-08-21       Impact factor: 7.640
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.